m6A modification variants were found in PD patients [218], and METTL3, METTL14, and YTHDF2 mRNA levels were lower in PD patients, suggesting that PD pathogenesis may be regulated via m6A modification [154]. This evidence concerns the gene METTL14 and Parkinson disease.